Chimeric Papillomavirus-like Particles (Q41098872)

26 September 2017

title

Chimeric papillomavirus-like particles (English)

1 reference

26 September 2017

Chimeric Papillomavirus-like Particles (English)

1 reference

Crossref

https://api.crossref.org/works/10.1006/VIRO.1997.8591

8 November 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9234950

8 November 2024

genetic recombination

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9234950

8 November 2024

M. Müller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9234950

8 November 2024

J. Zhou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9234950

8 November 2024

T. D. Reed

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9234950

8 November 2024

C. Rittmüller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9234950

8 November 2024

A. Burger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9234950

8 November 2024

J. Gabelsberger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9234950

8 November 2024

J. Braspenning

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9234950

8 November 2024

L. Gissmann

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9234950

8 November 2024

language of work or name

English

0 references

publication date

1 July 1997

1 reference

26 September 2017

21 July 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9234950

full work available at URL

8 November 2024

https://doi.org/10.1006/viro.1997.8591

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9234950

https://api.elsevier.com/content/article/PII:S0042682297985913?httpAccept=text/xml

8 November 2024

1 reference

Crossref

https://api.crossref.org/works/10.1006/VIRO.1997.8591

https://api.elsevier.com/content/article/PII:S0042682297985913?httpAccept=text/plain

8 November 2024

1 reference

Crossref

https://api.crossref.org/works/10.1006/VIRO.1997.8591

8 November 2024

1 reference

26 September 2017

volume

234

1 reference

26 September 2017

1 reference

26 September 2017

page(s)

93-111

1 reference

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

26 September 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/EJI.1830230929

Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Vaccination against papillomavirus in cattle

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Detection of human serum antibodies that neutralize infectious human papillomavirus type 11 virions

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6.

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

A COMPARATIVE STUDY OF POLYOMA AND PAPILLOMA VIRUSES

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Human Papillomavirus Type 16 and Early Cervical Neoplasia

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Structural polypeptides of rabbit, bovine, and human papillomaviruses

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Human papillomavirus 16 E7 protein is associated with the nuclear matrix

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Human papillomavirus type 16 capsid proteins produced from recombinant Semliki Forest virus assemble into virus-like particles

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Site-directed mutagenesis by overlap extension using the polymerase chain reaction

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Analysis of human papillomavirus type 16 late mRNA 3' processing signals in vitro and in vivo

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7.

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Papillomavirus capsid binding and uptake by cells from different tissues and species.

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Carboxyl terminus of bovine papillomavirus type-1 L1 protein is not required for capsid formation

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

A system for rapid DNA sequencing with fluorescent chain-terminating dideoxynucleotides

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Virus-like particles induce MHC class I-restricted T-cell responses. Lessons learned from the hepatitis B small surface antigen

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Structure and transcription of human papillomavirus sequences in cervical carcinoma cells

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Titration of HPV-11 Infectivity and Antibody Neutralization Can Be Measured In Vitro

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Transforming proteins of the papillomaviruses

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Serologic response in human papillomavirus-associated invasive cervical cancer

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Identification of the nuclear localization signal of human papillomavirus type 16 L1 protein

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles.

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Synthesis and assembly of infectious bovine papillomavirus particles in vitro

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Early phase in the infection of cultured cells with papillomavirus virions

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers

8 November 2024

1 reference

https://api.crossref.org/works/10.1006/VIRO.1997.8591

8 November 2024

Identifiers

1 reference

26 September 2017

1 reference